Commerzbank Aktiengesellschaft’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-80,304	Closed	-$13.9M	–	1245
2015 Q1	$13.9M	Sell	80,304 -26,122	-25%	-$3.83M	0.08%	175
2014 Q4	$12.2M	Sell	106,426 -55,623	-34%	-$6.74M	0.08%	218
2014 Q3	$25.3M	Buy	162,049 +112,866	+229%	+$16.4M	0.1%	159
2014 Q2	$6.07M	Buy	49,183 +40,533	+469%	+$4.48M	0.03%	413
2014 Q1	$896K	Buy	8,650 +2,752	+47%	+$282K	﹤0.01%	863
2013 Q4	$574K	Buy	5,898 +291	+5%	+$23.2K	﹤0.01%	1016
2013 Q3	$375K	Sell	5,607 -241	-4%	-$16.6K	﹤0.01%	1077
2013 Q2	$387K	Buy	+5,848	New	+$334K	﹤0.01%	1146

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Commerzbank Aktiengesellschaft's SLXP Position: Q2 2015 in Review

Commerzbank Aktiengesellschaft sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 80,304 shares — an estimated $13.9M sold.

Commerzbank Aktiengesellschaft first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $25.3M in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Commerzbank Aktiengesellschaft reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Commerzbank Aktiengesellschaft sold 80,304 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $13.9M.
Commerzbank Aktiengesellschaft first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Commerzbank Aktiengesellschaft's SALIX PHARMACEUTICALS LTD DEL position peaked at $25.3M in Q3 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q2 2015, filed 10 Aug 2015.